Professor of Medical Oncology; Director, Early Drug Development Division · University of Milan; European Institute of Oncology, IRCCS
Specialty: Oncology
Based in Milan, Italy
Giuseppe Curigliano, MD, PhD, directs early drug development at the European Institute of Oncology and is Professor of Medical Oncology at the University of Milan. His research focuses on biomarkers, targeted agents and personalised cancer therapies, including phase I–III breast cancer trials. ESMO identifies him as President-Elect.